About Beth Seidenberg, M.D.
Form D filings for Kate Therapeutics in 2024 list Beth Seidenberg, M.D. as director.
Beth Seidenberg, M.D. first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Beth Seidenberg, M.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Beth Seidenberg, M.D. works with at each company, as listed on that company's latest Form D.
Kate Therapeutics Inc. · Form D, Aug 7, 2024
CD
Clare Ozawa, Ph.D.
Director
KD
Kevin Forrest, Ph.D.
Chief Executive Officer and director